{
  "docId": "019de070-c58c-706c-98f1-9eec26811648",
  "docSlug": "2a1e5b2d3a1cb25fe50abb3e75ae9bdf",
  "documentTitle": "Alkermes | Investor Day Presentation Deck | 144 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 92,
  "pageCount": 132,
  "prevPage": 91,
  "nextPage": 93,
  "slideType": "other",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a biological process flow diagram to explain the therapeutic rationale.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de070-c58c-706c-98f1-9eec26811648/92",
  "deckHref": "/decks/019de070-c58c-706c-98f1-9eec26811648",
  "deckJsonHref": "/decks/019de070-c58c-706c-98f1-9eec26811648.json",
  "deckAnchorHref": "/decks/019de070-c58c-706c-98f1-9eec26811648#slide-92",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.53,
        "x": 0.06,
        "y": 0.21
      },
      "kind": "diagram",
      "text": "Mechanism of action diagram showing growth factor receptors being inhibited, leading to reduced tumor survival/metastasis and increased immune response.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2ffdb90e-b898-4645-90e5-d9ba50a0510d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.35,
        "x": 0.6,
        "y": 0.28
      },
      "kind": "list",
      "text": "Growth factors support several mechanisms that promote cancer cell survival and metastasis. Inhibition of tumor growth factor pathways is a validated therapeutic approach. T cell mediated immune responses may be augmented by nemvaleukin.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ec543388-7031-443b-bb4c-8d106456d5a2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.58,
        "y": 0.85
      },
      "kind": "source-note",
      "text": "1. Loery Fl et. al. Cancer Metastasis Rev. 2012; 2. Witsch E, et.al. Physiology 2010; 3. ESMO Oncology. 2021",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d1416f7d-52b4-4a1b-9430-2da851ef9ce8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.05,
        "y": 0.07
      },
      "kind": "title",
      "text": "Inhibition of Growth Factor Pathways Induces Immunogenic Cancer Cell Death",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b4ee529c-a2fc-49fe-9f55-41f8578ec51a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "causal-chain",
      "slug": null,
      "matchId": "127a9c2c-9aa4-4e9a-afe4-434b34a3c688",
      "evidence": "The diagram maps the causal sequence from inhibitor application to T cell activation.",
      "confidence": 0.85
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}